NEC OncoImmunity AS
Maria Slanova is a highly experienced Senior Machine Learning Engineer currently at NEC OncoImmunity AS, with a progressive career in data science and machine learning since January 2017. Previous roles include Machine Learning Engineer at Schibsted and Data Scientist at Kantox, where significant contributions were made in developing analytical dashboards, recommendation systems, and customer churn models. Maria's expertise in data collection, preprocessing, and collaboration with cross-functional teams has been instrumental in enhancing business intelligence tools and customer analytics. Earlier experience encompasses project management and analytical roles at Artics Internet Solutions and Tinkoff Credit Systems, as well as data mining internships focused on oncological data analysis. Educational qualifications include master's degrees in Data Mining and Knowledge Management, and a degree in Applied Informatics from prominent institutions.
NEC OncoImmunity AS
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.